Evidence map›Paper›PMID 41821445›Full record

ArticleRadiation protection dosimetry2026

Optimization of radiation protection using diagnostic reference values: current approaches and future directions.

Anja Almén

Abstract read
In one paragraph

Article in Radiation protection dosimetry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Anja AlménMedical Radiation Physics, Department of Translational Medicine, Lund University, Inga Marie Nilssons gata 47, SE-205 02 Malmö, Sweden.ORCID 0000-0003-0792-1294

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnostic reference levels (DRLs) were introduced as a tool to optimize radiation protection in medical imaging. Conditions for dose assessment have evolved significantly. This study explores how effectively the current DRL system functions and whether it requires adjustment. The analysis focuses on the national DRL system in Sweden and includes European projects and guidelines for reference. The variability in typical doses has decreased. National DRL values have been lowered; however, values in nuclear medicine have seen minimal change. These developments present challenges in revising the values. The increased availability of digital data offers both opportunities and challenges. The DRL system may include specific indications, larger patient cohorts, and consideration of patient size. To remain relevant, the DRL system must be updated to reflect changes in clinical practice. The integration of image quality assessment into the DRL framework is one critical area that requires further development.

Indexed as

Diagnostic ImagingNuclear MedicineRadiation ProtectionDiagnostic Reference LevelsHumansRadiation DosageRadiation MonitoringRadiometryReference ValuesSweden

Identifiers

PMID41821445
PMCPMC13046050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.